Renal pro-inflammatory cytokine gene expression in diabetic nephropathy:: Effect of angiotensin-converting enzyme inhibition and pentoxifylline administration

被引:187
|
作者
Navarro, Juan F.
Milena, Francisco J.
Mora, Carmen
Leon, Candelaria
Garcia, Javier
机构
[1] Hosp Univ Nuestra Senora Candelaria, Serv Nefrol, ES-38010 Tenerife, Spain
[2] Hosp Univ Nuestra Senora Candelaria, Res Unit, ES-38010 Tenerife, Spain
[3] Hosp Univ Nuestra Senora Candelaria, Clin Biochem Serv, ES-38010 Tenerife, Spain
[4] Spanish Natl Res Council, Madrid, Spain
关键词
angiotensin II; diabetic nephropathy; enalapril; interleukin; 1; 6; pentoxifylline; tumor necrosis factor-alpha;
D O I
10.1159/000098004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Recent studies have shown a role for inflammation in the pathogenesis of diabetic nephropathy (DN). Tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 and IL-6 are cytokines with a prevalent pro-inflammatory activity. Our objective was to study the renal gene expression of TNF-alpha, IL-1 and IL-6 in DN and their relationship with renal damage assessed by urinary albumin excretion (UAE). In addition, we also investigated the effect of angiotensin-converting enzyme inhibition and pentoxifylline (PTF) administration on these parameters. Methods: After streptozotocin-induced diabetes, rats received either no treatment or therapy with enalapril (EN) or PTF for 8 weeks. Renal expression of proinflammatory cytokines was evaluated by real-time polymerase chain reaction. Urinary cytokine excretion and albuminuria were also evaluated. Results: Renal cortical mRNA expression for TNF-alpha, IL-1 and IL-6 in untreated diabetic rats was 2.4-, 1.2- and 3.4-fold higher than in non-diabetic rats. Kidney weight and UAE were significantly associated with renal mRNA expression of TNF-alpha and IL-6. Both EN and PTF administration virtually abrogated the overexpression of TNF-alpha, IL-1 and IL-6, which was associated with a reduction in kidney weight and urinary albumin excretion. Conclusion: The renal expression of the main pro-inflammatory cytokines TNF-alpha, IL-1 and IL-6 is increased in DN, which is significantly associated with UAE. EN and PTF administration prevented this enhanced expression, leading to a decrease in urinary cytokine excretion and a reduction in albuminuria. These findings provide novel insight into the pathogenic mechanisms of DN, supporting the hypothesis that inflammatory mechanisms play a role in the renal injury secondary to diabetes mellitus. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:562 / 570
页数:9
相关论文
共 50 条
  • [41] THE BENEFICIAL EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION WITH CAPTOPRIL ON DIABETIC NEPHROPATHY IN NORMOTENSIVE IDDM PATIENTS WITH MICROALBUMINURIA
    LAFFEL, LMB
    MCGILL, JB
    GANS, DJ
    AMERICAN JOURNAL OF MEDICINE, 1995, 99 (05): : 497 - 504
  • [42] Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
    Ferrario, CM
    Jessup, J
    Chappell, MC
    Averill, DB
    Brosnihan, KB
    Tallant, EA
    Diz, DI
    Gallagher, PE
    CIRCULATION, 2005, 111 (20) : 2605 - 2610
  • [43] Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Blockade on Streptozotocin-Induced Diabetic Nephropathy
    Saniye, Sen
    Mehmet, Kanter
    Sedat, Ustundag
    Cevat, Aktas
    Dogutan, Haluk
    Omer, Yalcin
    RENAL FAILURE, 2008, 30 (10) : 1023 - 1033
  • [44] Preservation of Kidney Function with Combined Inhibition of NADPH Oxidase and Angiotensin-Converting Enzyme in Diabetic Nephropathy
    Thallas-Bonke, Vicki
    Coughlan, Melinda T.
    Bach, Leon A.
    Cooper, Mark E.
    Forbes, Josephine M.
    AMERICAN JOURNAL OF NEPHROLOGY, 2010, 32 (01) : 73 - 82
  • [45] Angiotensin-converting enzyme gene polymorphism in chronic allograft nephropathy
    Biselli, P. M.
    Abbud-Filho, M.
    Ferreira-Baptista, M. A. S.
    de Alvarenga, M. P. S.
    Goloni-Bertollo, E. M.
    Pavarino-Bertelli, E. C.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (05) : 1327 - 1328
  • [46] Effect of therapy with sulodexid and angiotensin-converting enzyme inhibitor (ACEI) on current diabetic nephropathy
    Mjuntal, Olena
    Dudar, Irina
    Krot, Victor
    Kryzhanyvska, Vera
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 86 - 87
  • [47] Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: Observational follow up study
    Parving, HH
    Jacobsen, P
    Tarnow, L
    Rossing, P
    Lecerf, L
    Poirier, O
    Cambien, F
    BRITISH MEDICAL JOURNAL, 1996, 313 (7057): : 591 - 594
  • [48] Relationship between polymorphism of the angiotensin-converting enzyme gene and the response to angiotensin-converting enzyme inhibition in hypertensive patients
    Yu, HM
    Zhang, YQ
    Liu, GZ
    HYPERTENSION RESEARCH, 2003, 26 (11) : 881 - 886
  • [49] Clinical and economic benefits of angiotensin-converting enzyme inhibitors in diabetic nephropathy
    Brenner, L
    Finkelstein, S
    Brenner, BM
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1999, 8 (02): : 243 - 249
  • [50] USEFULNESS OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS FOR THE THERAPY OF DIABETIC NEPHROPATHY
    ROMERO, R
    SANMARTI, A
    SALINAS, I
    TEIXIDO, J
    FOZ, M
    CARALPS, A
    MEDICINA CLINICA, 1988, 90 (12): : 494 - 496